Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. [electronic resource]
Producer: 20040520Description: 395-402 p. digitalISSN:- 0022-3417
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Hormonal -- therapeutic use
- Biomarkers, Tumor -- genetics
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Disease-Free Survival
- Female
- Gene Expression
- Humans
- Middle Aged
- Neoplasm Proteins -- metabolism
- Prognosis
- Proportional Hazards Models
- RNA, Messenger -- genetics
- RNA, Neoplasm -- genetics
- Tamoxifen -- therapeutic use
- Tissue Inhibitor of Metalloproteinase-3 -- genetics
- Tissue Inhibitor of Metalloproteinases -- metabolism
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.